Bioceres reports Q3 revenue $60.6M, consensus $61.87M

Federico Trucco, Bioceres (BIOX)’ CEO, commented: “Our third fiscal quarter is typically uneventful, as it falls in the off-season for most of our geographies. This year, however, it stands out for a non-P&L achievement: our exceptional cash flow performance. The $40 million improvement on a year-over-year basis reflects disciplined execution across the organization, and we are very pleased with the outcome.”